Insider Transactions in Q1 2021 at Eye Point Pharmaceuticals, Inc. (EYPT)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 28
2021
|
Nancy Lurker |
BUY
Exercise of conversion of derivative security
|
Direct |
12,467
+10.26%
|
-
|
|
Feb 28
2021
|
John B. Landis |
BUY
Exercise of conversion of derivative security
|
Direct |
1,900
+24.36%
|
-
|
|
Feb 28
2021
|
David R Guyer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,900
+50.0%
|
-
|
|
Feb 28
2021
|
Douglas Evan Godshall |
BUY
Exercise of conversion of derivative security
|
Direct |
1,900
+25.62%
|
-
|
|
Feb 28
2021
|
Wendy F Dicicco |
BUY
Exercise of conversion of derivative security
|
Direct |
1,900
+50.0%
|
-
|
|
Feb 28
2021
|
Goran Ando |
BUY
Exercise of conversion of derivative security
|
Direct |
2,150
+50.0%
|
-
|
|
Feb 28
2021
|
David Scott Jones SVP & Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,702
-18.74%
|
$17,020
$10.81 P/Share
|
|
Feb 28
2021
|
David Scott Jones SVP & Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,105
+31.13%
|
-
|
|
Feb 28
2021
|
Dario A. Paggiarino Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,423
-10.93%
|
$14,230
$10.81 P/Share
|
|
Feb 28
2021
|
Dario A. Paggiarino Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,105
+23.98%
|
-
|
|
Feb 21
2021
|
Nancy Lurker |
BUY
Exercise of conversion of derivative security
|
Direct |
13,717
+12.44%
|
-
|